David M Sherry Selected Research

6-Cyano-7-nitroquinoxaline-2,3-dione (6 Cyano 7 nitroquinoxaline 2,3 dione)

5/2008	Contribution of voltage-gated sodium channels to the b-wave of the mammalian flash electroretinogram.
11/2007	Voltage-gated sodium channel alpha-subunits Na(v)1.1, Na(v)1.2, and Na(v)1.6 in the distal mammalian retina.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David M Sherry Research Topics

Disease

7	Ganglion Cysts (Ganglion) 10/2015 - 12/2003
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2019
1	Gliosis 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Cognitive Dysfunction 01/2022
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2019
1	Retinal Degeneration 01/2019
1	Gait Ataxia 01/2019
1	Atrophy 01/2019
1	Macular Degeneration (Age-Related Maculopathy) 01/2019
1	Hypoxia (Hypoxemia) 01/2018
1	Brain Injuries (Brain Injury) 01/2018
1	Brain Hypoxia (Cerebral Hypoxia) 01/2018
1	Ischemia 01/2018
1	Seizures (Absence Seizure) 01/2018
1	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2015
1	Photophobia (Light Sensitivity) 01/2013
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 06/2011
1	Epilepsy (Aura) 06/2010
1	Optic Nerve Injuries 05/2008
1	Fibrosis (Cirrhosis) 11/2004

Drug/Important Bio-Agent (IBA)

4	Retinaldehyde (Retinal)IBA 10/2015 - 05/2008
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2010
2	6-Cyano-7-nitroquinoxaline-2,3-dione (6 Cyano 7 nitroquinoxaline 2,3 dione)IBA 05/2008 - 11/2007
1	Serine (L-Serine)FDA Link 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	NociceptinIBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	NeuropeptidesIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Apoptosis Regulatory ProteinsIBA 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2015
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 10/2015
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2015
1	MelatoninIBA 01/2013
1	Dopamine (Intropin)FDA LinkGeneric 01/2013
1	Melatonin Receptors (Melatonin Receptor)IBA 04/2012
1	Insulin (Novolin)FDA Link 06/2011
1	N-Methylaspartate (NMDA)IBA 05/2008
1	Excitatory Amino Acid AgonistsIBA 05/2008
1	Ionotropic Glutamate ReceptorsIBA 05/2008
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2004
1	Protein Isoforms (Isoforms)IBA 09/2004
1	Vesicle-Associated Membrane Protein 1IBA 12/2003
1	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 12/2003
1	Cholinergic Agents (Cholinergics)IBA 12/2003

Therapy/Procedure

1	Therapeutics 01/2019
1	Intravitreal Injections 05/2008